Los Angeles Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Los Angeles Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-502,107	Closed	-$1.56M	–	1544
2021 Q4	$1.56M	Sell	502,107 -89,920	-15%	-$303K	0.01%	586
2021 Q3	$2.14M	Sell	592,027 -42,020	-7%	-$159K	0.01%	518
2021 Q2	$2.27M	Sell	634,047 -62,300	-9%	-$220K	0.01%	560
2021 Q1	$2.72M	Sell	696,347 -135,940	-16%	-$561K	0.01%	538
2020 Q4	$3.5M	Buy	832,287 +45,043	+6%	+$174K	0.01%	485
2020 Q3	$2.94M	Buy	787,244 +117,735	+18%	+$501K	0.01%	464
2020 Q2	$2.92M	Buy	669,509 +132,925	+25%	+$597K	0.01%	516
2020 Q1	$2.03M	Buy	536,584 +323,205	+151%	+$1.59M	0.01%	532
2019 Q4	$1.35M	Sell	213,379 -86,565	-29%	-$509K	0.01%	748
2019 Q3	$1.26M	Hold	299,944	–	–	0.01%	748
2019 Q2	$1.4M	Buy	+299,944	New	+$1.4M	0.01%	738

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Los Angeles Capital Management's BDSI Position: Q1 2022 in Review

Los Angeles Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 502,107 shares — an estimated $1.56M sold.

Los Angeles Capital Management first reported a position in BDSI in Q2 2019 and held it in 11 quarters. The position peaked at $3.5M in Q4 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Los Angeles Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Los Angeles Capital Management sold 502,107 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1.56M.
Los Angeles Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 11 quarters.
Los Angeles Capital Management's BioDelivery Sciences International, Inc. position peaked at $3.5M in Q4 2020.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Los Angeles Capital Management's 13F filing for Q1 2022, filed 6 May 2022.